GTR Home > Tests > Search results - C1876161[DISCUI]

Apply filters

Showing tests for all 2661 conditions

Compare labs

Your search term can be found in tests with a total of 2661 conditions. Only 1000 conditions are displayed in this filter box. Please type the name of the condition in the search box in this filter to find the specific condition. You can use the filters below to narrow down your results.
If the name of the condition you typed is not present, please try another query or search using the All GTR tab.

  • Hide states
More locations

GTR test search results for C1876161[DISCUI]

C Clinical test, R Research test

Showing 1 to 20 of 52 tests for 2661 conditions in 24 labs

CTPP1-Related Neuronal Ceroid-Lipofuscinosis

Lab: Clinical Molecular Genetics Laboratory All Children's Hospital St. Petersburg, Florida, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNeuronal Ceroid-Lipofuscinoses Panel

Lab: Genetic Services Laboratory University of Chicago Chicago, Illinois, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
Total conditions (8)
Total targets (8)

CCeroid lipofuscinosis, neuronal type 2

Lab: Centogene AG - the Rare Disease Company Rostock, Mecklenburg-Vorpommern, Germany
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region

CEarly Infantile Epileptic Encephalopathy NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (65)
Total targets (63)

CNeuronal Ceroid Lipofuscinoses (Batten Disease) NextGen Sequencing (NGS) Panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (15)
Total targets (13)

CEarly Infantile Epileptic Encephalopathy, Recessive NextGen Sequencing (NGS) panel

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • D Deletion/duplication analysis
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis
Total conditions (42)
Total targets (40)

CTruGenome Predisposition Screen (Whole Genome Sequencing)

Lab: Illumina Clinical Services Laboratory Illumina San Diego, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (1541)
Total targets (1578)

CepiSEEK® Infancy and Childhood Epilepsy Panel

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Total conditions (72)
Total targets (70)

CComprehensive Epilepsy Panel

Lab: Transgenomic New Haven, Connecticut, United States
Total conditions (524)
Total targets (374)

CNeuronal Ceroid Lipofuscinosis 2 via the TPP1 Gene

Lab: PreventionGenetics Marshfield, Wisconsin, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region

CNuclearMitome Test

Lab: Transgenomic New Haven, Connecticut, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (385)
Total targets (433)

CTPP1-Related Neuronal Ceroid Lipofuscinosis

Lab: Counsyl South San Francisco, California, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
  • T Targeted variant analysis

CepiSEEK® Comprehensive Sequence Analysis for Epilepsy and Seizure Disorders (489 genes)

Lab: Courtagen Diagnostics Laboratory Courtagen Life Sciences Woburn, Massachusetts, United States
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (641)
Total targets (439)

CPan-Ethnic Carrier Screen: Gene Sequencing Panel

Test targets
Methods
  • D Deletion/duplication analysis
  • E Sequence analysis of select exons
  • C Sequence analysis of the entire coding region
Total conditions (136)
Total targets (147)

CRetinal Dystrophy Panel

Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (254)
Total targets (183)

CNeuronal Ceroidlipofuscinosis (NCL) Panel

Lab: CeGaT GmbH Tuebingen, Baden-Wurttemberg, Germany
Test targets
Methods
  • C Sequence analysis of the entire coding region
Total conditions (24)
Total targets (22)

Showing 1 to 20 of 52 tests for 2661 conditions in 24 labs

IMPORTANT NOTE: NIH does not independently verify information submitted to the GTR; it relies on submitters to provide information that is accurate and not misleading. NIH makes no endorsements of tests or laboratories listed in the GTR. GTR is not a substitute for medical advice. Patients and consumers with specific questions about a genetic test should contact a health care provider or a genetics professional.